76 related articles for article (PubMed ID: 7530850)
1. E-cadherin expression in prostatic carcinoma biopsies: correlation with tumor grade, DNA content, pathologic stage, and clinical outcome.
Ross JS; Figge HL; Bui HX; del Rosario AD; Fisher HA; Nazeer T; Jennings TA; Ingle R; Kim DN
Mod Pathol; 1994 Oct; 7(8):835-41. PubMed ID: 7530850
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression in prostate cancer: a broad survey using high-density tissue microarray technology.
Rubin MA; Mucci NR; Figurski J; Fecko A; Pienta KJ; Day ML
Hum Pathol; 2001 Jul; 32(7):690-7. PubMed ID: 11486167
[TBL] [Abstract][Full Text] [Related]
3. Metallothionein expression in prostatic carcinoma: correlation with Gleason grade, pathologic stage, DNA content and serum level of prostate-specific antigen.
Moussa M; Kloth D; Peers G; Cherian MG; Frei JV; Chin JL
Clin Invest Med; 1997 Dec; 20(6):371-80. PubMed ID: 9413634
[TBL] [Abstract][Full Text] [Related]
4. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer.
Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB
Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067
[TBL] [Abstract][Full Text] [Related]
5. DNA ploidy and proliferation heterogeneity in human prostate cancers.
Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
[TBL] [Abstract][Full Text] [Related]
6. Smad4 protein expression correlates with grade, stage, and DNA ploidy in prostatic adenocarcinomas.
Sheehan GM; Kallakury BV; Sheehan CE; Fisher HA; Kaufman RP; Ross JS
Hum Pathol; 2005 Nov; 36(11):1204-9. PubMed ID: 16260274
[TBL] [Abstract][Full Text] [Related]
7. Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers.
Kuniyasu H; Troncoso P; Johnston D; Bucana CD; Tahara E; Fidler IJ; Pettaway CA
Clin Cancer Res; 2000 Jun; 6(6):2295-308. PubMed ID: 10873080
[TBL] [Abstract][Full Text] [Related]
8. Expression of the CD44 cell adhesion molecule in urinary bladder transitional cell carcinoma.
Ross JS; del Rosario AD; Bui HX; Kallakury BV; Okby NT; Figge J
Mod Pathol; 1996 Aug; 9(8):854-60. PubMed ID: 8871928
[TBL] [Abstract][Full Text] [Related]
9. [Correlation and significance of E-cadherin and N-cadherin expression in prostate cancer].
Huang X; Zhou LQ; Ai JK; Lu YQ; Bai Y; Zeng L; Zhang ZW; Guo YL
Ai Zheng; 2002 Nov; 21(11):1208-11. PubMed ID: 12526217
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of E-cadherin and beta-catenin in human prostate cancer.
Jaggi M; Johansson SL; Baker JJ; Smith LM; Galich A; Balaji KC
Urol Oncol; 2005; 23(6):402-6. PubMed ID: 16301117
[TBL] [Abstract][Full Text] [Related]
11. Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy.
Sengupta S; Cheville JC; Lohse CM; Zincke H; Myers RP; Riehle DL; Pankratz VS; Blute ML; Sebo TJ
Urology; 2006 Jul; 68(1):94-8. PubMed ID: 16844452
[TBL] [Abstract][Full Text] [Related]
12. Pan-cadherin as a high level phenotypic biomarker for prostate cancer.
Wehbi NK; Dugger AL; Bonner RB; Pitha JV; Hurst RE; Hemstreet GP
J Urol; 2002 May; 167(5):2215-21. PubMed ID: 11956481
[TBL] [Abstract][Full Text] [Related]
13. p53 expression, proliferation marker Ki-S5, DNA content and serum PSA: possible biopotential markers in human prostatic cancer.
Papadopoulos I; Rudolph P; Wirth B; Weichert-Jacobsen K
Urology; 1996 Aug; 48(2):261-8. PubMed ID: 8753738
[TBL] [Abstract][Full Text] [Related]
14. The relative mRNA expression levels of matrix metalloproteinase to E-cadherin in prostate biopsy specimens distinguishes organ-confined from advanced prostate cancer at radical prostatectomy.
Kuniyasu H; Ukai R; Johnston D; Troncoso P; Fidler IJ; Pettaway CA
Clin Cancer Res; 2003 Jun; 9(6):2185-94. PubMed ID: 12796385
[TBL] [Abstract][Full Text] [Related]
15. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
[TBL] [Abstract][Full Text] [Related]
16. Unmethylated E-cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.
Saha B; Kaur P; Tsao-Wei D; Naritoku WY; Groshen S; Datar RH; Jones LW; Imam SA
Prostate; 2008 Nov; 68(15):1681-8. PubMed ID: 18712716
[TBL] [Abstract][Full Text] [Related]
17. Deoxyribonucleic acid ploidy status as no basis for pathologic stage prediction in clinically resectable prostate cancer.
Egawa S; Satoh T; Iwamura M; Aihara M; Kuwao S; Uchida T; Koshiba K
Urology; 1996 Apr; 47(4):548-52. PubMed ID: 8638366
[TBL] [Abstract][Full Text] [Related]
18. Expression of p27kip1 in prostatic adenocarcinoma.
Cheville JC; Lloyd RV; Sebo TJ; Cheng L; Erickson L; Bostwick DG; Lohse CM; Wollan P
Mod Pathol; 1998 Apr; 11(4):324-8. PubMed ID: 9578081
[TBL] [Abstract][Full Text] [Related]
19. N-cadherin switching occurs in high Gleason grade prostate cancer.
Jaggi M; Nazemi T; Abrahams NA; Baker JJ; Galich A; Smith LM; Balaji KC
Prostate; 2006 Feb; 66(2):193-9. PubMed ID: 16173043
[TBL] [Abstract][Full Text] [Related]
20. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
